scholarly journals The Effects of the Angiotensin II Receptor Antagonist Losartan on Appetitive Versus Aversive Learning: A Randomized Controlled Trial

2019 ◽  
Vol 86 (5) ◽  
pp. 397-404 ◽  
Author(s):  
Erdem Pulcu ◽  
Lorika Shkreli ◽  
Carolina Guzman Holst ◽  
Marcella L. Woud ◽  
Michelle G. Craske ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Angiotensin Ii ◽  
Receptor Antagonist ◽  
Controlled Trial ◽  
Aversive Learning ◽  
Angiotensin Ii Receptor ◽  
Angiotensin Ii Receptor Antagonist ◽  
Randomized Controlled

scholarly journals Angiotensin II Receptor Antagonist Attenuates Expression of Aging Markers in Diabetic Mouse Heart

2006 ◽  
Vol 70 (4) ◽  
pp. 482-488 ◽  
Author(s):  
Rie Kosugi ◽  
Tetsuo Shioi ◽  
Kayo Watanabe-Maeda ◽  
Yuki Yoshida ◽  
Keiko Takahashi ◽  
...  
Keyword(s):  
Angiotensin Ii ◽  
Receptor Antagonist ◽  
Diabetic Mouse ◽  
Mouse Heart ◽  
Angiotensin Ii Receptor ◽  
Angiotensin Ii Receptor Antagonist

scholarly journals Losartan (DuP 753), An Orally Active Nonpeptide Angiotensin II Receptor Antagonist

1991 ◽  
Vol 9 (4) ◽  
pp. 317-339 ◽  
Author(s):  
Pancras C. Wong ◽  
T. Bradford Barnes ◽  
Andrew T. Chiu ◽  
David D. Christ ◽  
John V. Duncia ◽  
...  
Keyword(s):  
Angiotensin Ii ◽  
Receptor Antagonist ◽  
Angiotensin Ii Receptor ◽  
Angiotensin Ii Receptor Antagonist ◽  
Orally Active
Sign in / Sign up

Export Citation Format

Share Document